Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
1.090
-0.060 (-5.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Adagio Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | 0.6 | 0.3 | 0.19 | 0.27 |
| Revenue Growth (YoY) | - | 100.67% | 58.73% | -30.00% | - |
| Cost of Revenue | 0.68 | 3.32 | 1.31 | 0.88 | 1.16 |
| Gross Profit | -0.68 | -2.72 | -1.01 | -0.69 | -0.89 |
| Selling, General & Admin | 10.57 | 20.02 | 11.54 | 5.37 | 4.4 |
| Research & Development | 10.64 | 12.22 | 15.4 | 17.86 | 15.36 |
| Operating Expenses | 21.21 | 32.24 | 26.94 | 23.23 | 19.76 |
| Operating Income | -21.89 | -34.96 | -27.94 | -23.91 | -20.65 |
| Interest Expense | -2.91 | -2.92 | -1.66 | -0.14 | - |
| Interest & Investment Income | 0.48 | 0.42 | 0 | 0.04 | 0 |
| Other Non Operating Income (Expenses) | -0.77 | 11.62 | -6.99 | 0.34 | -0.04 |
| EBT Excluding Unusual Items | -25.08 | -25.84 | -36.59 | -23.67 | -20.68 |
| Impairment of Goodwill | - | -30.32 | - | - | - |
| Asset Writedown | - | -18.88 | - | - | - |
| Other Unusual Items | - | - | - | - | 0.74 |
| Pretax Income | -25.08 | -75.04 | -36.59 | -23.67 | -19.94 |
| Net Income | -25.08 | -75.04 | -36.59 | -23.67 | -19.94 |
| Net Income to Common | -25.08 | -75.04 | -36.59 | -23.67 | -19.94 |
| Shares Outstanding (Basic) | 17 | 7 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 17 | 7 | 1 | 1 | 1 |
| Shares Change (YoY) | 147.85% | 780.27% | 1.10% | 2.36% | - |
| EPS (Basic) | -1.51 | -11.22 | -48.16 | -31.50 | -27.15 |
| EPS (Diluted) | -1.51 | -11.22 | -48.16 | -31.50 | -27.15 |
| Free Cash Flow | -19.39 | -31.11 | -25.99 | -22.9 | -20.57 |
| Free Cash Flow Per Share | -1.17 | -4.65 | -34.20 | -30.48 | -28.01 |
| Operating Margin | - | -5806.98% | -9314.00% | -12652.38% | -7646.30% |
| Profit Margin | - | -12465.28% | -12196.67% | -12525.40% | -7384.44% |
| Free Cash Flow Margin | - | -5167.28% | -8661.67% | -12118.52% | -7616.67% |
| EBITDA | -20.92 | -33.57 | -27.41 | -23.42 | -20.31 |
| D&A For EBITDA | 0.97 | 1.39 | 0.53 | 0.5 | 0.34 |
| EBIT | -21.89 | -34.96 | -27.94 | -23.91 | -20.65 |
Source: S&P Capital IQ. Standard template.
Financial Sources.